1700040I university of texas medical branch; pre-clinical models of infectious diseases; to A29OBRRTR--18 base award; biod can 8470038; $1,179,674.00
Ended Awarded Last action
- Contract number
- 75N93019F00271
- Awardee
-
University Of Texas Medical Branch At Galveston UEI MSPWVMXXMN76 Part of University Of Texas System
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,501,902
Award facts
- Opportunity
-
- NIHAI2016059 Solicitation number
- Contract value 55% obligated
-
- $1,501,902.34 Current, with exercised options
- $2,706,323.34 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Galveston, TX 77555, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$116,233 | |
| Close Out | -$765,959 | |
| Exercise an Option | $500,747 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $703,674 | |
| Original award | $1,179,674 |
About this award
This is a $1,179,674.00 delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to the University of Texas Medical Branch at Galveston (UTMB). The contract is for pre-clinical models of infectious diseases research and is part of NIAID's Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery contract vehicle, which has a total ceiling value of $2,706,323.34. UTMB, a state-run educational institution with extensive experience in biomedical research, is performing this work without any set-aside designation. This award allows NIAID to efficiently order a range of preclinical R&D services from UTMB to support the evaluation of candidate therapeutics, vaccines, and diagnostics against various pathogens, including emerging infectious diseases.
Quick answers
Who was awarded contract 75N93019F00271?
75N93019F00271 was awarded to University Of Texas Medical Branch At Galveston by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 13, 2019.
How much is contract 75N93019F00271 worth?
The government has obligated $1,501,902 on 75N93019F00271. Its potential value, with all options, is $2,706,323.
Is contract 75N93019F00271 an order under another contract?
Yes. 75N93019F00271 is a delivery order under HHSN272201700040I, an indefinite delivery contract, on NIAID Preclinical Models of Infectious Diseases 2017-2024.
Was contract 75N93019F00271 competed?
The extent of competition for 75N93019F00271 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award